Blood Processing Supplies And Equipment
November 15, 2013 10:32 ET
|
Research and Markets
Dublin, Nov. 15, 2013 (GLOBE NEWSWIRE) -- Blood Processing Supplies And Equipment - Global
Strategic Business Report - 2012
Research and Markets...
Blood Pressure Monitoring And Measurement Instruments - Global Strategic Business Report 2013
November 07, 2013 09:36 ET
|
Research and Markets
Dublin, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/kf8bt2/blood_pressure)
has announced the addition of the "Blood
Pressure Monitoring And...
Arch Therapeutics Co-Founder Dr. Ellis-Behnke to Speak at Nanomanufacturing Summit 2013 in Philadelphia, October 15, 2013
October 10, 2013 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Oct 10, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), is pleased to announce that co-founding and inventing scientist, Dr. Rutledge...
Arch Therapeutics Announces Approval of $1 Million Massachusetts Life Sciences Center Accelerator Loan
October 07, 2013 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Oct 7, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27
September 20, 2013 09:00 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Sep 20, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), today announced it will be featured as a presenting company at the Boulder Peptide...
Arch Therapeutics Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
September 03, 2013 09:00 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Sep 3, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), today announced it will be featured as a presenting company at the 15th Annual Rodman...
Arch Therapeutics Announces Plans for Upcoming Activities
August 06, 2013 15:05 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Aug 6, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...
GAME INSIGHT BLASTS OFF WITH EPIC INTERSTELLAR ADVENTURE ON IPAD IN STARBORN WANDERERS
August 01, 2013 13:29 ET
|
Game Insight (Cooper Media Corp.)
MOSCOW and SAN FRANCISCO, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Game Insight, a world leader in mobile/social games, has announced Starborn Wanderers for iPad, a brand-new game and intellectual property...
Arch Therapeutics Reports on Current Activities
July 30, 2013 09:00 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 30, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...
Arch Therapeutics Co-Founder Dr. Ellis-Behnke Speaks at 6th Annual CLINAM Nanomedicine Summit in Basel, Switzerland
July 23, 2013 09:50 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 23, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...